Comportamiento de la Creatinina, el Hematocrito y el Sodio en pacientes egresados con diagnostico de Insuficiencia Cardiaca
Autor: MSc. Dra. Natascha Mezquia de Pedro | Publicado:  21/10/2008 | Analisis Clinicos , Cardiologia , Medicina Interna | |
Comportamiento de Creatinina, Hematocrito y Sodio en pacientes con Insuficiencia Cardiaca.5

Bibliografía

1.     Ministerio de Salud Pública. Dirección Nacional de Estadísticas. 2003. Cuba. Principales causas de muerte de todas las edades 1970, 1981, 1993, 2002-2003. [en línea. URL disponible en: http://bvs.sld.cu/ cgi-in/ wxis/ anuario/ ?IsisScript= anuario /iah.xis&tag5001= mostrar ^m1010&tag 5009=STANDARD &tag5008=10&tag5007=Y&tag5003= anuario&tag5021= e&tag5022=2003&tag5023=1010 con acceso mayo 2007

2.     Alexander RW et cols. Manual HURST. El corazón, p. 1-17. 9ª ed.; 2000.

3.     López Castro J. La Insuficiencia Cardiaca. Epidemiología y Abordaje diagnostico. Arch. Med. Vol 1 No 1 Art. 9. 2005

4.     de la Serna Fernando. INSUFICIENCIA CARDIACA CRÓNICA.. Capítulo 10: Clínica de la I.C. (2da. parte) Actualización 1er. Semestre/2006, pgs 250/292

5.     Rozman C, García San Miguel J, Feliu E et col. FARRERAS/ROZMAN. Medicina Interna. IC. P. 553-564. 14ª ed.; 2000.

6.     Alfaro D Mario. , Hospital Dipreca, Insuficiencia Cardíaca I. Medwave. Año 2, No. 8, Edición Septiembre 2002, de la Serna Fernando. INSUFICIENCIA CARDIACA CRÓNICA.. Capítulo 10: Clínica de la I.C. (2da. parte) Actualización 1er. Semestre/2006, págs 250/292

7.     de la Serna Fernando. INSUFICIENCIA CARDIACA CRÓNICA.. Capítulo 10: Clínica de la I.C. (2da. parte) Actualización 1er. Semestre/2006, 250-292)

8.     Ryan P, Montoya J, Gibbs D, Méndez-Bailon M, Muñoz N, Calvo E. ¿ Existe el Síndrome de anemia cardiorrenal? Arch. Med. Vol. 1 No 1 art. 8 2005

9.     Garrido MD J. SÍNDROME CARDIO-RENAL. ¿ES LA ANEMIA EL FACTOR DECISIVO DE LA FUNCIÓN VENTRICULAR EN LOS PACIENTES CON INSUFICIENCIA RENAL E INSUFICIENCIA CARDIACA? Rev Electron Biomed / Electron J Biomed 2005; 2:2-8

10.   Díaz Novas at.el. Rev. Cubana Med. Gen Integral. 20 n.2 Ciudad de La Habana mar.-abr. 2004

11.   Multanosky MP. Historia de la medicina. La Habana: Academia de Ciencias de Cuba; 1967. p. 78-88.

12.   Pita Fernández S, Valdés Cañedo F. Determinación de factores pronósticos Cad Aten Primaria 1997; 4: 26-29

13.   Tang WHW, Miller H, Partin M, et al: Anemia in ambulatory patients with chronic heart failure: A single-center clinical experience derived from electronic medical records. J Amer Coll Cardiol 41 Suppl A: 157A, 2003.

14.   Wexler D, Silverberg D, Sheps D, Blum M, Keren G, Iaina A, Schwartx D. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. Int J Cardiol 2004, 96(1): 79-87.

15.   Silverberg DS, Wexler D, Blum M, Iaina A. The cardio renal anemia syndrome: correcting anemia in patients with resistant congestive heart failure can improve both cardiac and renal function and reduce hospitalizations. Clin Nephrol. 2003 Jul; 60 Suppl 1:S93-102.

16.   Thierer J. Insuficiencia Cardiaca o por que no relajarse cuando la fracción de eyección esta conservada. Rev. Arg. De Cardiología. vol. 71 No 4 Julio-Agosto 2003.

17.   Wisniacki N, Aimson P, Lyle M: Is anemia a cause of heart failure in the elderly? Heart 85(Suppl 1): P4, 2001

18.   Tanner H, Moschovitis G, Kuster GM, et al: The prevalence of anemia in chronic heart failure. Int J Cardiol 86: 115-121, 2002

19.   Horwich TB, Fonarow GC, Hamilton MA, et al: Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39: 1780-1786, 2002

20.   Polanczyk CA, Newton C, Dec GC, Di Salvo TG: Quality of care and hospital readmission in congestive heart failure: An explicit review process. J Card Fail 7: 289-298, 2001

21.   Okonko DO, Anker SD. Anemia in chronic heart failure: pathogenetic mechanisms. J Card Fail 2004, 10 Suppl: S5-9.

22.   Steinborn W, Doehner W, Anker SD. Anemia in chronic heart failure- frequency an prognostic impact. Clin Nephrol 2003, Suppl 1:S103-107. http://biomed.uninet.edu/ 2005/ n2/ editorial.html

23.   Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, O'Connor CM. Usefulness of anemia as a predictor of death and rehospitalizacion in patients with decompensated heart failure. Am J Cardiol 2003, 92:625-628?

24.   Eckardt KU. Managing a fateful alliance: anaemia and cardiovascular outcomes. Nephrol Dial Transplant 2005, 20 Suppl 6:vi16-vi20.

25.   Gregory DD, Sarnak MJ, Konstam MA, Pereira B, Salem D. Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction. Am J Cardiol 2003, 92:1300-1305.

26.   Herzog CA, Muster HA, Li S, Collins AJ. Impact of congestive heart failure, chronic kidney disease and anemia on survival in the Medicare population. J Card Fail 2004, 10:467- 72.

27.   Levin A: The relationship of hemoglobin level and survival: Direct or indirect effects. Neph Dial Transplant 17(Suppl 5): 8-13, 2002

28.   Siems WG, Sommerburg O, Grune T: Erythrocyte free radical and energy formation. Clin Nephrol 53(Suppl 1): S9-S17, 2000

29.   Grune T, Sommerburg O, Siems WG: Oxidative stress in anemia. Clin Nephrol 53(Suppl 1): S18-S22, 2000

30.   Kristal B, Shurtz-Swirski R, Shasha SM, et al: Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in hemodialysis patients. Nephron 81: 406-413, 1998

31.   Silverberg DS, Wexler D, Blum M, et al: The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and renal failure and markedly reduces hospitalization. Clin Nephrol 58(Suppl 1): S37-S45, 2002

32.   Silverberg DS, Wexler D, Blum M, et al: The effect of correction of anemia in diabetic and non diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 18: 141-146, 2003

33.   Cortina A, Cortina R. Insuficiencia Cardiaca: marcadores de pronósticos de mortalidad. Cardiovascular risk factors vol. 10 No 1Feb. 2001

34.   Silverberg DS, Wexler D, Blum M, et al: The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35: 1737-1744, 2000

35.   Levin A, Djurdjev O, Barrett B, et al: Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter. Am J Kidney Dis 38: 1398-1407, 2001

36.   GALLI C N., CAMUS J M, FISCHER E I. Terapia sustitutiva renal en la insuficiencia cardíaca refractaria al tratamiento médico. Rev. Fed. Arg. Cardiol. 2006; 35: 4-8

37.   Ezekowitz J, McAlister FA, Humphries KH y col: The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004; 44: 1587-1592.

38.   GALLI C N., CAMUS J M, FISCHER E I. Terapia sustitutiva renal en la insuficiencia cardíaca refractaria al tratamiento médico. Rev. Fed. Arg. Cardiol. 2006; 35: 4-8

39.   Lisowska A, Musial WJ: Heart failure in the patients with chronic kidney disease. Ann Acad Med Bialostecensis 2004; 49: 162-165.

40.   Manjunath G, Tighiouart H, Coresh J, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63:1121-1129.

41.   Klarenbach S, Stafinski T, Longobardi T, Jacobs P. The effect of renal insufficiency on workforce participation in the United States: an analysis using National Health and Nutrition Examination Survey III data. Am J Kidney Dis 2002; 40: 1132-1137.

42.   García, MD D. La conexión cardio-renal Rev. Soc. Colombiana de Card.Volumen 11 Número 2 – 2004 ver en URL: http: // www.javascript: showHidex con acceso Junio 2007

43.   Sarnak MJ, Schoolwerth AC, Coresh J, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology and epidemiology and prevention. Circulation 2003; 108:2154- 2169.

44.   Weiner DE, Tighiouart H, Amin M, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004; 15: 1307-1315.

45.   Silverberg D, Wexler D, Blum M, et al. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens 2004; 13: 163-170.

46.   Arandia J, Silvestre Arze R. Epidemiología de la hiponatremia en el Centro Médico Boliviano Belga Rev. Nefrol. Diál. y Transpl. , N° 31 - Marzo 1992, Pág. 9-17

 

 


Revista Electronica de PortalesMedicos.com
INICIO - NOVEDADES - ÚLTIMO NÚMERO - ESPECIALIDADES - INFORMACIÓN AUTORES
© PortalesMedicos, S.L.
PortadaAcerca deAviso LegalPolítica de PrivacidadCookiesPublicidadContactar